Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer

Gefitinib (GFT) is a tyrosine kinase inhibitor drug used as a first-line treatment for patients with advanced or metastatic non-small cell lung, colon, and breast cancer. GFT exhibits low solubility and hence low oral bioavailability, which restricts its clinical application. One of the most importa...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Shenawy, Ahmed A., Elsayed, Mahmoud M. A., Atwa, Gamal M. K., Abourehab, Mohammed A. S., Mohamed, Mohamed S., Ghoneim, Mohammed M., Mahmoud, Reda A., Sabry, Shereen A., Anwar, Walid, El-Sherbiny, Mohamed, Hassan, Yasser A., Belal, Amany, Ramadan, Abd El hakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960579/
https://www.ncbi.nlm.nih.gov/pubmed/36840004
http://dx.doi.org/10.3390/pharmaceutics15020680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960579/
https://www.ncbi.nlm.nih.gov/pubmed/36840004
http://dx.doi.org/10.3390/pharmaceutics15020680

Ejemplares similares